We're here for you if you want to talk

0808 2080 888

[email protected]

Our funding schemes

We provide funding for laboratory-based research projects to address important questions in the field of blood cancer.

We're implementing our new research strategy and will be opening more funding calls in the coming year.

Research projects

Applications to the following scheme are considered by our Research Funding Committee.

Project grants - call for applications

Project grants are awarded for up to £280,000 and up to three years, for clearly defined research projects addressing key questions in the field of blood cancer.

The remit of the project grant scheme includes Trial-Associated Research Projects, which are laboratory-based projects associated with a fully-funded clinical trial that aim to address a clearly defined research question to maximise the value and outcome of the trial.

Please note that new applications for biobank funding will not be considered.

Further details of the scheme are included in the Project grant guidance document, or contact the research team with queries ([email protected]).

All applications must be submitted via the Grant Tracker.

  • 15 June 2022 - project funding round opens
  • 6 September 2022 - 4pm deadline for submission of applications
  • March 2023 - outcomes will be known by this date

If you have grant application queries, please contact the research team at [email protected]

For this funding call, applications that align to either of the two prioritised areas below are invited:

  1. Improving understanding of fundamental disease processes - including underlying areas such as disease origin, transformation, and relapse, so that we can better predict, and in the future prevent, blood cancer.
  2. Improving treatment options for the individual – including personalised approaches and immunotherapies, resulting in improved survival with fewer side effects (due to less toxic treatments).

For more information on these priorities, please see the above guidance document and our research strategy page.

A separate funding call for applications in research priority area 3 - 'Developing novel approaches to the use of data' will open at the end of July 2022.

Funding decisions are made on the basis of scientific quality. Success rates vary over time due the levels of funding available, the level of demand from the research community and quality of applications received.

2018/2019 summary:

82 grant funding applications received;

17 awards were made with a total value of £4.38 million;

21% success rate (all grants).

2019/2020 summary:

52 grant funding applications received;

15 awards were made with a total value of £3.71 million;

29% success rate (all grants).

2020/2021 summary:

47 grant funding applications received;

9 awards were made with a total value of £2.57 million;

19% success rate (all grants).

2021/2022 summary:

30 project grant funding applications received;

13 awards made with a total value of £3.03 million;

43% success rate (all grants).

Partnership funding schemes

We work with other national and international funders to support innovative blood cancer research.

Our research strategy includes a goal of developing new partnerships, bringing new funding into blood cancer research and accelerating progress by strengthening collaboration. Most recently, we have come together with industry partners and other charities to lead the Vaccine Research Collaborative.

Where there is alignment of specific research interests, with funding partners, we may prioritise research into particular conditions or themes.

If you feel that you have a research proposal that may be appropriate for partnership funding, please contact our research team.

Clinical and Non-clinical Research Fellowships

We are proud to once again offer funding to support early career researcher careers. Specifically, this support is aimed at helping scientists to become independent investigators through a programme of research and training lasting up to five years.

We have a long history of funding in this area via a range of schemes, including the Gordon Piller PhD studentships, Bennett fellowships for post-doctoral researchers, and Clinical Research Training fellowships for haematologists training for a PhD and Lectureships.

Both clinical and non-clinical fellowships below are funded in a partnership with the Medical Research Council (MRC).

Discontinued grant schemes

This funding scheme has been discontinued and no new funding rounds are due to open.

For further enquiries, please contact the research team at [email protected].

This funding scheme has been discontinued and no new funding rounds are due to open.

For further enquiries, please contact the research team at [email protected].

At present there are no open rounds for this committee.